[3-(1-methylimidazol-2-yl)-1-(4-propylthiadiazol-5-yl)propyl]hydrazine

C12H20N6S — CID 105340304

IUPAC[3-(1-methylimidazol-2-yl)-1-(4-propylthiadiazol-5-yl)propyl]hydrazine
SMILESCCCc1nnsc1C(CCc1nccn1C)NN
InChIInChI=1S/C12H20N6S/c1-3-4-10-12(19-17-16-10)9(15-13)5-6-11-14-7-8-18(11)2/h7-9,15H,3-6,13H2,1-2H3
InChIKeyMONHHSALJUAEOM-UHFFFAOYSA-N
MW280.40 g/mol
LogP1.36
Rot. Bonds7

About [3-(1-methylimidazol-2-yl)-1-(4-propylthiadiazol-5-yl)propyl]hydrazine

[3-(1-methylimidazol-2-yl)-1-(4-propylthiadiazol-5-yl)propyl]hydrazine (PubChem CID 105340304) has the molecular formula C12H20N6S and a molecular weight of 280.40 g/mol. Its IUPAC name is [3-(1-methylimidazol-2-yl)-1-(4-propylthiadiazol-5-yl)propyl]hydrazine.

Molecular Properties

Compound Name[3-(1-methylimidazol-2-yl)-1-(4-propylthiadiazol-5-yl)propyl]hydrazine
PubChem CID105340304
Molecular FormulaC12H20N6S
Molecular Weight280.40 g/mol
Exact Mass280.15
IUPAC Name[3-(1-methylimidazol-2-yl)-1-(4-propylthiadiazol-5-yl)propyl]hydrazine
SMILESCCCc1nnsc1C(CCc1nccn1C)NN
InChIInChI=1S/C12H20N6S/c1-3-4-10-12(19-17-16-10)9(15-13)5-6-11-14-7-8-18(11)2/h7-9,15H,3-6,13H2,1-2H3
InChIKeyMONHHSALJUAEOM-UHFFFAOYSA-N
XLogP1.36
TPSA81.65 Ų
H-Bond Donors2
H-Bond Acceptors7
Rotatable Bonds7
Heavy Atoms19
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500280.40
LogP ≤ 51.36
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 107

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'hydrazine', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}

Analyze [3-(1-methylimidazol-2-yl)-1-(4-propylthiadiazol-5-yl)propyl]hydrazine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

[2-(1-ethylimidazol-2-yl)-1-(4-propylthiadiazol-5-yl)ethyl]hydrazine
CID 105321812
[(1-ethylimidazol-2-yl)-(4-propylthiadiazol-5-yl)methyl]hydrazine
CID 105308426
[3-(1-methylimidazol-2-yl)-1-(5-methylpyrimidin-2-yl)propyl]hydrazine
CID 105261604
[3-(1-methylimidazol-2-yl)-1-(4-methylphenyl)propyl]hydrazine
CID 105194412
methanamine;1-methyl-2-propylimidazole
CID 164902083
[4-phenyl-1-(4-propylthiadiazol-5-yl)butyl]hydrazine
CID 105299779
[3-(1-methylimidazol-2-yl)-1-(1,2,5-thiadiazol-3-yl)propyl]hydrazine
CID 105340302
[3-(1-methylimidazol-2-yl)-1-(5-methylthiophen-2-yl)propyl]hydrazine
CID 105340288
[3-methyl-1-(4-propylthiadiazol-5-yl)hexyl]hydrazine
CID 105298123
4-[1-hydrazinyl-3-(1-methylimidazol-2-yl)propyl]-1-methylpyrazol-5-amine
CID 105230895
[1-(4-iodophenyl)-3-(1-methylimidazol-2-yl)propyl]hydrazine
CID 105340426
1-(4-ethylthiadiazol-5-yl)-2-(1-methylimidazol-2-yl)ethanamine
CID 105167023

Frequently Asked Questions

What is the IUPAC name of [3-(1-methylimidazol-2-yl)-1-(4-propylthiadiazol-5-yl)propyl]hydrazine?
The IUPAC name of [3-(1-methylimidazol-2-yl)-1-(4-propylthiadiazol-5-yl)propyl]hydrazine (CID 105340304) is [3-(1-methylimidazol-2-yl)-1-(4-propylthiadiazol-5-yl)propyl]hydrazine.
What is the SMILES notation for [3-(1-methylimidazol-2-yl)-1-(4-propylthiadiazol-5-yl)propyl]hydrazine?
The canonical SMILES for [3-(1-methylimidazol-2-yl)-1-(4-propylthiadiazol-5-yl)propyl]hydrazine is CCCc1nnsc1C(CCc1nccn1C)NN.
What is the InChIKey of [3-(1-methylimidazol-2-yl)-1-(4-propylthiadiazol-5-yl)propyl]hydrazine?
The InChIKey is MONHHSALJUAEOM-UHFFFAOYSA-N. The full InChI is InChI=1S/C12H20N6S/c1-3-4-10-12(19-17-16-10)9(15-13)5-6-11-14-7-8-18(11)2/h7-9,15H,3-6,13H2,1-2H3.
What are the key properties of [3-(1-methylimidazol-2-yl)-1-(4-propylthiadiazol-5-yl)propyl]hydrazine?
[3-(1-methylimidazol-2-yl)-1-(4-propylthiadiazol-5-yl)propyl]hydrazine has a molecular weight of 280.40 g/mol, XLogP of 1.36, 7 rotatable bonds, 2 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for [3-(1-methylimidazol-2-yl)-1-(4-propylthiadiazol-5-yl)propyl]hydrazine is sourced from PubChem (CID 105340304), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).